# Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection

> **NCT04350086** · PHASE4 · WITHDRAWN · sponsor: **University Hospital, Limoges**

## Conditions studied

- COVID-19 Infection
- Sars-cov-2
- Respiratory Failure
- Palliative Situation

## Interventions

- **DRUG:** Treatment with Dexmedetomidine

## Key facts

- **NCT ID:** NCT04350086
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-20
- **Primary completion:** 2020-11-20
- **Final completion:** 2020-11-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unfavorable opinion of the ethics committee
- **Last updated:** 2020-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04350086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04350086, "Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04350086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*